Primary record
[(19S)-10,19-diethyl-19-hydroxy-14,18-dioxo-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4(9),5,7,10,15(20)-heptaen-7-yl] 4-(2,2,3,3,4,4,5,5,6,6-decadeuteriopiperidin-1-yl)piperidine-1-carboxylate;hydrochloride
- 库存
- 2,259 克
- 纯度
- 99.8 %
- CAS
- 100286-90-6
化合物标识与属性
- CAS
- 100286-90-6
- PubChem CID
- 357467
- SMILES
- CCC1=C2CN3C(=CC4=C(C3=O)COC(=O)C4(CC)O)C2=NC5=C1C=C(C=C5)OC(=O)N6CCC(CC6)N7CCCCC7.Cl
- Canonical SMILES
- CCc1c2c(nc3ccc(OC(=O)N4CCC(N5CCCCC5)CC4)cc13)-c1cc3c(c(=O)n1C2)COC(=O)C3(O)CC.Cl
名称与同义词
- Irinotecan hydrochloride
- Topotecin
- Irinotecan Hcl
- Irinotecan-d10 HCl
- AC1L7AJI
- Irinotecan-d10 Hydrochloride
- C33H39ClN4O6
- SCHEMBL16447653
- MFCD01862255
- HMS5086J18
- 100286-90-6
- CID357467
- VN10007
- PD055308
- FT-0627291
- FT-0777627
- EN300-296083
- I14-1430
- Irinotecan hydrochloride anhydrous, Topoisomerase I Inhibitor
- (10,19-diethyl-19-hydroxy-14,18-dioxo-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4(9),5,7,10,15(20)-heptaen-7-yl) 4-(1-piperidyl)piperidine-1-carboxylate;hydrochloride
- (10,19-diethyl-19-hydroxy-14,18-dioxo-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4(9),5,7,10,15(20)-heptaen-7-yl) 4-piperidin-1-ylpiperidine-1-carboxylate;hydrochloride
- (S)-4,11-diethyl-3,4,12,14-tetrahydro-4-hydroxy- 3,14-dioxo1H-pyrano[3O,4O:6,7]-indolizino[1,2-b]quinolin- 9-yl-[1,4Obipiperidine]-1O-carboxylate HCl
- [(19S)-10,19-diethyl-19-hydroxy-14,18-dioxo-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4(9),5,7,10,15(20)-heptaen-7-yl] 4-(2,2,3,3,4,4,5,5,6,6-decadeuteriopiperidin-1-yl)piperidine-1-carboxylate;hydrochloride
- 10,19-diethyl-19-hydroxy-14,18-dioxo-17-oxa-3,13-diazapentacyclo[11.8.0.0^{2,11}.0^{4,9}.0^{15,20}]henicosa-1(21),2(11),3,5,7,9,15(20)-heptaen-7-yl [1,4'-bipiperidine]-1'-carboxylate hydrochloride
- 1184916-73-1
- 718612-62-5